International Journal of Molecular Medical Science, 2024, Vol.14, No.5, 264-273 http://medscipublisher.com/index.php/ijmms 10 Li N., Hu Y., Zhang X., Liu Y., He Y., Zee A., Schuuring E., and Wisman G., 2020, DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population, International Journal of Cancer, 148: 1768-1777. https://doi.org/10.1002/ijc.33430 Liang L.A., Einzmann T., Franzen A., Schwarzer K., Schauberger G., Schriefer D., Radde K., Zeissig S., Ikenberg H., Meijer C., Kirkpatrick C., Kölbl H., Blettner M., and Klug S.J., 2021, Cervical cancer screening: comparison of conventional Pap smear test, liquid-based cytology, and human papillomavirus testing as stand-alone or cotesting strategies, Cancer Epidemiology, Biomarkers & Prevention, 30(3): 474-484. https://doi.org/10.1158/1055-9965.EPI-20-1003 Lu J., Song E., Ghoneim A., and Alrashoud M., 2020, Machine learning for assisting cervical cancer diagnosis: an ensemble approach, Future Gener. Comput. Syst., 106: 199-205. https://doi.org/10.1016/j.future.2019.12.033 Malik S., Sah R., Muhammad K., and Waheed Y., 2023, Tracking HPV infection, associated cancer development, and recent treatment efforts-a comprehensive review, Vaccines, 11(1): 102. https://doi.org/10.3390/vaccines11010102 Mustafa W.A., Halim A., Jamlos M.A., and Idrus S.Z.S., 2020, A review: Pap smear analysis based on image processing approach, Journal of Physics: Conference Series, 1529( 2): 022080. https://doi.org/10.1088/1742-6596/1529/2/022080 Ntanasis-Stathopoulos I., Kyriazoglou A., Liontos M., Dimopoulos M.A., and Gavriatopoulou M., 2020, Current trends in the management and prevention of human papillomavirus (HPV) infection, J. Buon, 25(3): 1281-1285. https://doi.org/10.2478/fco-2019-0014 Reis R.S.D., Santos J.A.D., Abreu P.M.D., Dettogni R.S., Santos E.D.V.W.D., Stur E., Agostini L., Anders Q., Alves L., Valle I., Lima M., Souza E., Podestá J., Zeidler S., Cordeiro-Silva M., and Louro I.D., 2020, Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma, Genetics and Molecular Biology, 43(3): e20190334. https://doi.org/10.1590/1678-4685-gmb-2019-0334 Rerucha C.M., Caro R.J., and Wheeler V.L., 2018, Cervical cancer screening, American Family Physician, 97(7): 441-448. Sabeena S., Kuriakose S., Damodaran B., Ravishankar N., and Arunkumar G., 2020, Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis, Journal of Gynecologic Oncology, 31(2): e20. https://doi.org/10.3802/jgo.2020.31.e20 Salama A.M., Momeni-Boroujeni A., Vanderbilt C., Ladanyi M., and Soslow R., 2022, Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma, Modern Pathology, 35(2): 274-282. https://doi.org/10.1038/s41379-021-00942-3 Thomsen L.T., Kjær S.K., Munk C., Ørnskov D., and Waldstrøm M., 2021, Benefits and potential harms of human papillomavirus (HPV)‐based cervical cancer screening: a real‐world comparison of HPV testing versus cytology, Acta Obstetricia et Gynecologica Scandinavica, 100(3): 394-402. https://doi.org/10.1111/aogs.14121 Tu J., Chen S., Wu S., Wu T., Fan R., and Kuang Z., 2022, Tumor DNA methylation profiles enable diagnosis, prognosis prediction, and screening for cervical cancer, International Journal of General Medicine, 15: 5809-5821. https://doi.org/10.2147/IJGM.S352373 Wardle J., Robb K., Vernon S., and Waller J., 2015, Screening for prevention and early diagnosis of cancer, The American psychologist, 70(2): 119-133. https://doi.org/10.1037/a0037357 Wittenborn J., Weikert L., Hangarter B., Stickeler E., and Maurer J., 2020, The use of miRNA in the early detection of cervical intraepithelial neoplasia, Carcinogenesis, 43: 89-89. https://doi.org/10.1093/carcin/bgaa046 Zhang L., Tan W., Yang H., Zhang S., and Dai Y., 2022, Detection of host cell gene/HPV DNA methylation markers: a promising triage approach for cervical cancer, Frontiers in Oncology, 12: 831949. https://doi.org/10.3389/fonc.2022.831949 Zhong J.L., 2024, Epigenetic biomarkers in patients with hypertensive heart disease, International Journal of Molecular Medical Science, 14(2): 132-143. http://dx.doi.org/10.5376/ijmms.2024.14.0016
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==